Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Protaryx Medical
AddedFeb 15, 2024
UpdatedJun 18, 2026
Protaryx Medical

Protaryx Medical

Series A

Protaryx Medical: Innovating left atrium access for transcatheter cardiac procedures.

HQ
Baltimore, MD, US
Founded
2019
Overview
Compare
Fundraising
Employees
Website

Protaryx Medical is a medical device company focused on developing innovative solutions for left atrium access in transcatheter cardiac procedures. Their primary product is a differentiated transseptal access device designed to cross the atrial septum of the heart. This technology aims to streamline workflow efficiency and facilitate minimally invasive left heart interventional therapies, potentially improving outcomes for both physicians and patients.

Headquartered in Baltimore, Maryland, with engineering operations in Minneapolis, Minnesota, Protaryx Medical is committed to reimagining cardiac procedures. The company's innovative approach to left atrium access has the potential to significantly impact the field of interventional cardiology, offering new possibilities for catheter-based treatments and enhancing the overall efficiency of cardiac interventions.

Protaryx Medical - Similar Companies

Transverse Medical logo

Transverse Medical

Phoenix Cardiac logo

Phoenix Cardiac

Arstasis logo

Arstasis

arstasis.com

Laplace Interventional logo

Laplace Interventional

laplaceint.com

Prytime Medical Devices logo

Prytime Medical Devices

prytimemedical.com

Renata Medical logo

Renata Medical

renatamedical.com

Procyrion logo

Procyrion

Portela Soni Medical logo

Portela Soni Medical

Altrix Medical logo

Altrix Medical

altrixmedical.com

PathRight Medical logo

PathRight Medical

Ionix Medical logo

Ionix Medical

VytronUS logo

VytronUS

Traverse Vascular logo

Traverse Vascular

Saphena Medical logo

Saphena Medical

saphenamedical.com

MedicaMetrix logo

MedicaMetrix

medicametrix.com

Protaryx Medical - Quick Facts

Who are Protaryx Medical's competitors?

Companies similar to Protaryx Medical include Transverse Medical, Phoenix Cardiac, Arstasis and Laplace Interventional.

When was Protaryx Medical founded?

Protaryx Medical was founded in 2019.

Where is Protaryx Medical's headquarters located?

Protaryx Medical's headquarters is located in Baltimore, MD, US.

When was Protaryx Medical's last funding round?

Protaryx Medical's most recent funding round was for $5.1M (USD) in June 2020.

How much has Protaryx Medical raised to-date?

As of Jun 30, 2020, Protaryx Medical has raised a total of $8.3M (USD).

How many employees does Protaryx Medical have?

Protaryx Medical has 8 employees as of Feb 5, 2024.

Protaryx Medical - Classification

Industry
  • Hardware
Ownership
  • Venture Capital
Technology
  • Medical Devices
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified